Detalhe da pesquisa
1.
Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
N Engl J Med
; 386(18): 1700-1711, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353960
2.
Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trial.
J Neurol Neurosurg Psychiatry
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670789
3.
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial.
J Infect Dis
; 227(11): 1266-1273, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722044
4.
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials.
Transfusion
; 63(9): 1639-1648, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534607
5.
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?
Transfusion
; 62(5): 933-941, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352362
6.
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
JCI Insight
; 9(8)2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483534
7.
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
medRxiv
; 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131659
8.
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern.
Blood Adv
; 6(12): 3678-3683, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443020
9.
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern.
medRxiv
; 2022 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262085
10.
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.
medRxiv
; 2021 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981068